| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/04/2013 | CN102755283B Water-in-oil medicament nanodispersion compound thermosensitive hydrogel and preparation method thereof |
| 09/04/2013 | CN102697788B Compound lactic acid levofloxacin oral liquid and preparation process thereof |
| 09/04/2013 | CN102697761B 一种布洛芬缓释固体组合物及其制备方法 An extended release solid composition and preparation method ibuprofen |
| 09/04/2013 | CN102670501B Orally taken vitamin K1 lipid emulsion |
| 09/04/2013 | CN102670492B Production process for gatifloxacin auristilla |
| 09/04/2013 | CN102659950B LHRH-bonded amphiphilic biodegradable polymer, preparation method and application |
| 09/04/2013 | CN102657875B ANT1 gene-based targeted immunoliposome, preparation method thereof and application thereof |
| 09/04/2013 | CN102657599B Method for preparing bioactive injectable hydrogel materials for oncotherapy |
| 09/04/2013 | CN102649841B Polyethylene glycol-modified phospholipid derivative taking anilino-quinazoline as targeting ligand and preparation method thereof |
| 09/04/2013 | CN102641421B Figwort Shangqing gula tablet |
| 09/04/2013 | CN102631562B Blood-activating, pain-relieving and bone-strengthening ointment |
| 09/04/2013 | CN102604065B Cross-linked biologically degradable carrier polymer, micelle and vesicle, and preparation method and application of the cross-linked biologically degradable carrier polymer, micelle and vesicle |
| 09/04/2013 | CN102600082B Preparation method of tumor targeting nano-preparation |
| 09/04/2013 | CN102600080B Enzymatic type cleavable PEGylation ( polyethylene glycol) lipid material |
| 09/04/2013 | CN102580051B Oral liquid for treating hepatitis A |
| 09/04/2013 | CN102579848B Chinese medicine for treating lumbocrural pain |
| 09/04/2013 | CN102579828B Orally-taken traditional Chinese medical capsule for treatment of breast cancer |
| 09/04/2013 | CN102579473B Nifuratel-nysfungin gel and preparation method thereof |
| 09/04/2013 | CN102552221B Tulobuterol patch and preparation method thereof |
| 09/04/2013 | CN102526673B Chinese medicine capsule, Chinese medicine liquid and health-care oral liquid for treating dilated cardiomyopathy and manufacture method |
| 09/04/2013 | CN102526447B Manufacturing method of external medicine for treating low rectal cancer |
| 09/04/2013 | CN102512382B Esomeprazole sodium pharmaceutical composition for injection |
| 09/04/2013 | CN102430050B Black plaster for treating bone injury |
| 09/04/2013 | CN102423330B Blumea riparia tablet and preparation process thereof |
| 09/04/2013 | CN102406631B Method for improving transfer rate of chrysophanol |
| 09/04/2013 | CN102389511B Anti-radiation Chinese medicine preparation and preparation method thereof |
| 09/04/2013 | CN102379949B Preparation process of sini powder |
| 09/04/2013 | CN102370615B 一种布洛芬注射制剂及其制备方法 One kind of injectable formulation of ibuprofen and its preparation method |
| 09/04/2013 | CN102335272B Liquid preparation for diminishing inflammation and preparation method thereof |
| 09/04/2013 | CN102319209B Nasal pharmaceutical formulations and methods of using the same |
| 09/04/2013 | CN102281879B Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone |
| 09/04/2013 | CN102274475B Ostalgia moxibustion |
| 09/04/2013 | CN102188386B Nimesulide sustained-release pellets and preparation method thereof |
| 09/04/2013 | CN102176903B Iron source product in the form of capsules and process for their preparation |
| 09/04/2013 | CN102159184B Liquid pharmaceutical formulation containing paracetamol |
| 09/04/2013 | CN102028742B Drug for treating coronary heart disease and extraction method thereof |
| 09/04/2013 | CN102028741B Medicament for treating coronary heart disease and extraction thereof |
| 09/04/2013 | CN101721708B ED-71 preparation |
| 09/04/2013 | CN101686903B DMS in foaming creams |
| 09/04/2013 | CN101633657B Preparation method of palonosetron and palonosetron hydrochloride and injection |
| 09/04/2013 | CN101505794B scFV antibodies which pass epithelial and/or endothelial layers |
| 09/04/2013 | CN101146517B Methods and systems for operating an aerosol generator |
| 09/03/2013 | US8524829 Methods for micronization of hydrophobic drugs |
| 09/03/2013 | US8524784 Polymer micelles containing anthracylines for the treatment of cancer |
| 09/03/2013 | US8524783 Polymer micelles containing anthracylines for the treatment of cancer |
| 09/03/2013 | US8524779 Emulsion compositions containing quaternary ammonium compounds |
| 09/03/2013 | US8524774 Topical two step polytherapy for treatment of psoriasis and other skin disorders |
| 09/03/2013 | US8524773 Utilization of dialkylfumarates |
| 09/03/2013 | US8524770 Wool care composition |
| 09/03/2013 | US8524759 Phenylbutazone carrier formulation showing increased bioactivity in animals |
| 09/03/2013 | US8524701 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 09/03/2013 | US8524698 Methods of treating hypertriglyceridemia |
| 09/03/2013 | US8524696 Water-soluble compositions of bioactive lipophilic compounds |
| 09/03/2013 | US8524692 Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof |
| 09/03/2013 | US8524368 Charge-dynamic polymers and delivery of anionic compounds |
| 09/03/2013 | US8524280 Methods for enhancing the release and absorption of water insoluble active agents |
| 09/03/2013 | US8524279 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale. |
| 09/03/2013 | US8524278 Controlled release pharmaceutical formulations of nitazoxanide |
| 09/03/2013 | US8524277 Extended release dosage form |
| 09/03/2013 | US8524276 Oral formulations and lipophilic salts of methylnaltrexone |
| 09/03/2013 | US8524275 Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent |
| 09/03/2013 | US8524274 Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof |
| 09/03/2013 | US8524273 Transdermal absorption preparation |
| 09/03/2013 | US8524272 Transdermal patch incorporating active agent migration barrier layer |
| 09/03/2013 | US8524271 Skin wound dressing and preparing method thereof |
| 09/03/2013 | US8524270 Cross-linked gelatin composition coated with a wetting agent |
| 09/03/2013 | US8524269 Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions |
| 09/03/2013 | US8524267 Dexamethasone formulations in a biodegradable material |
| 09/03/2013 | US8524264 Protein stabilized antimicrobial composition formed by melt processing |
| 09/03/2013 | US8524260 Method for encapsulating oils in an aqueous medium with hase polymer emulsions, products obtained, and uses thereof |
| 09/03/2013 | US8524257 A free-flowing body of peppermint oil-free l-menthol having anticaking particles of silicon dioxides adhering to its surface; antiagglomerants; storage stability; mint flavor for foods and dental, cosmetic, drug, tobacco and confectionary products; sustained release |
| 09/03/2013 | US8524256 Deodorant cosmetic composition comprising at least one semicrystalline polymer |
| 09/03/2013 | US8524254 Bioresorbable polymers |
| 09/03/2013 | US8524253 Bone regeneration device |
| 09/03/2013 | US8524213 Cohesive gel of hyaluronic acid or hylan crosslinked with divinyl sulfone characterized by percentage modification and ratio of crosslinks to pendant groups; use treating, osteoarthritis, preventing surgical adhesions, soft tissue augmentation, drug delivery systems |
| 09/03/2013 | US8524203 Sunscreen composite particles for UVA and UVB protection |
| 09/03/2013 | US8524198 Reducing plaque, suppressing bacterial growth; fluoride free, nontoxic, safe; pastes, chewing gums |
| 09/03/2013 | US8524197 Chewable antiplaque confectionery dental composition |
| 09/03/2013 | US8524196 Method of providing fast relief to a user of a nicotine chewing gum |
| 09/03/2013 | CA2806767A1 Patch and method for producing the same |
| 09/03/2013 | CA2747000C Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 09/03/2013 | CA2657090C Clear pharmaceutical aqueous microemulsion comprising propofol and process for preparation |
| 09/03/2013 | CA2630738C Immunostimulatory oligoribonucleotides |
| 09/03/2013 | CA2612080C Immediate-release therapeutic systems for improved oral absorption of 7-[(e)-t-butyloxyiminomethyl] camptothecin |
| 09/03/2013 | CA2603081C Device and methods for treating paranasal sinus conditions |
| 09/03/2013 | CA2565029C Immediate release pharmaceutical tablets with height greater than width |
| 09/03/2013 | CA2548559C Intranasal compositions comprising granisetron and chitosan |
| 09/03/2013 | CA2530783C Drop pills prepared from excipients derived from natural sources |
| 09/03/2013 | CA2515262C Treatment of bacterial diseases of the respiratory organs |
| 09/03/2013 | CA2489308C Use of taurine for the treatment of alopecia |
| 09/03/2013 | CA2386810C Electrospun skin masks and uses thereof |
| 08/29/2013 | WO2013126919A1 Nemo binding domain fusion proteins |
| 08/29/2013 | WO2013126799A1 Compositions and methods for ocular delivery of a therapeutic agent |
| 08/29/2013 | WO2013126776A1 Nanostructures for treating cancers and other conditions |
| 08/29/2013 | WO2013126697A1 Transdermal compositions and methods for treating stretch marks |
| 08/29/2013 | WO2013126552A1 Buprenorphine nanoparticle composition and methods thereof |
| 08/29/2013 | WO2013126155A1 Ophthalmic compositions with alkoxylated natural waxes |
| 08/29/2013 | WO2013126149A1 Process to improve feed efficiency and carcass characteristics of animals |
| 08/29/2013 | WO2013126017A1 Organogels and emulsions for biological and non-biological applications |
| 08/29/2013 | WO2013124869A2 The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations |